- Conditions
- Locally Recurrent Prostate Cancer
- Interventions
- PRX302
- Drug
- Lead sponsor
- Sophiris Bio Corp
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 2
- States / cities
- San Antonio, Texas • Temple, Texas
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- PRX302, Placebo
- Drug
- Lead sponsor
- Sophiris Bio Corp
- Industry
- Eligibility
- 50 Years to 80 Years · Male only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2013
- U.S. locations
- 15
- States / cities
- Laguna Hills, California • Long Beach, California • Newport Beach, California + 12 more
- Conditions
- Prostate Cancer
- Interventions
- PSA-Activated PSA-PAH1
- Drug
- Lead sponsor
- Sophiris Bio Corp
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2006 – 2008
- U.S. locations
- 1
- States / cities
- Temple, Texas
- Conditions
- Prostate Cancer
- Interventions
- PRX302
- Drug
- Lead sponsor
- Sophiris Bio Corp
- Industry
- Eligibility
- 40 Years and older · Male only
- Enrollment
- 38 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 4
- States / cities
- Ocala, Florida • Baltimore, Maryland • New York, New York + 1 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- PRX302, Placebo
- Drug · Other
- Lead sponsor
- Sophiris Bio Corp
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 479 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 45
- States / cities
- Huntsville, Alabama • Anchorage, Alaska • Laguna Hills, California + 40 more